Literature DB >> 1310410

Interactions between anticollagen antibodies and chondrocytes.

T Takagi1, H E Jasin.   

Abstract

OBJECTIVE: To investigate the interactions between anticollagen antibodies and living chondrocytes.
METHODS: Mouse monoclonal anti-type II collagen (anti-CII) antibodies, rabbit anti-human CII, and rat anti-CII, anti-CIV, anti-CV, anti-CVI, and anti-CIX were studied in vitro to determine their ability to bind to the plasma membrane of living bovine chondrocytes.
RESULTS: Mouse monoclonal anti-CII, rabbit anti-CII, and rat anti-CII, anti-CV, and anti-CIX were shown to bind in vitro to the plasma membrane of bovine chondrocytes. Antibody binding was not observed with anti-CIV, or with chondrocytes previously incubated with bacterial collagenase. A significant increase in chondrocyte caseinase and collagenase secretion was observed following sequential incubation with the monoclonal antibodies and a source of activating cytokines.
CONCLUSION: These results suggest that collagen autoantibodies may exert some of their pathogenic effects on cartilage through interactions with resident chondrocytes, leading to modulation of the rate of secretion of cartilage matrix-degrading enzymes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1310410     DOI: 10.1002/art.1780350217

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  3 in total

Review 1.  Immunopathogenesis of osteoarthritis.

Authors:  Abdul Haseeb; Tariq M Haqqi
Journal:  Clin Immunol       Date:  2013-01-06       Impact factor: 3.969

Review 2.  Success rates and immunologic responses of autogenic, allogenic, and xenogenic treatments to repair articular cartilage defects.

Authors:  Christopher M Revell; Kyriacos A Athanasiou
Journal:  Tissue Eng Part B Rev       Date:  2009-03       Impact factor: 6.389

Review 3.  Antigenic and immunogenic properties of chondrocytes. Implications for chondrocyte therapeutic transplantation and pathogenesis of inflammatory and degenerative joint diseases.

Authors:  Anna Osiecka-Iwan; Anna Hyc; Dorota M Radomska-Lesniewska; Adrian Rymarczyk; Piotr Skopinski
Journal:  Cent Eur J Immunol       Date:  2018-06-30       Impact factor: 2.085

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.